Strategic Objectives
• Master the signaling pathways sensitive to nano-scale triggers.
• Identify the mechanisms behind nanoparticle-induced immunosuppression.
• Understand the difference between innate and adaptive responses to synthetics.
• Evaluate the latest safety protocols for clinical nanomedicine application.
The Core Challenge
As nanomaterials become ubiquitous in medicine and industry, our immune systems are encountering triggers they never evolved to handle, leading to unpredictable inflammatory and toxicological risks.
01
The Dawn of Immunonanotoxicology
02
The Biological Identity
03
First Responders
04
The Complement Cascade
05
Phagocytosis and Clearance
06
The Inflammasome Trigger
07
Oxidative Stress Mechanisms
08
Adaptive Immunity and Nanomaterials
09
Cytokine Storms
10
Immunosuppression and Silencing
11
Toll-Like Receptors
12
Nanoparticles as Adjuvants
13
Dendritic Cells at the Hub
14
Hypersensitivity and Allergy
15
The Lymphatic Highway
16
Genotoxicity and the Immune Cell
17
Apoptosis and Necrosis
18
Chronic Inflammation and Fibrosis
19
In Vitro Screening Methods
20
Regulatory Perspectives
21